Physician Experts Highlight Research Ahead of Otolaryngology’s Annual Meeting

The latest research on ear health, head and neck cancer, sleep-disordered breathing, rhinology and allergy, facial plastics, laryngology and swallowing disorders, endocrine surgery, and other topics related to otolaryngology-head and neck surgery will be presented in Atlanta, GA, October 7-10, during the 2018 Annual Meeting & OTO Experience of the American Academy of Otolaryngology-Head and Neck Surgery Foundation.

Abstracts of all the research to be presented are now available online.

The 2018 Annual Meeting includes hundreds of research presentations. The program advisory committee, comprised of physician members, selected 21 scientific oral presentations to highlight in recognition of outstanding scientific merit and innovation. The following selected studies will be presented during the “Best of Orals” session on Sunday, October 7, at 8:30 am in Building B, Room 312, in the Georgia World Congress Center (GWCC).

Do Surgeons’ Biases Influence the Treatment Decisions in Patients with Recurring Tonsillitis?
Nish Mehta, PhD, MBBS, FRCS (ORL) (presenter)

Effectiveness of Non-opioid/Non-narcotic Postoperative Pain Management Regimen for Patients Undergoing Thyroidectomy and/or Parathyroidectomy
James Biery (presenter) and Phillip K. Pellitteri, DO

Epidemiology of Vestibular Schwannoma over the Past Half-Century: Population-Based Study in the United States
John P. Marinelli BS, (presenter), Christine Lohse, MS, and Matthew L. Carlson, MD

Evaluation of the Prognostic Utility of the Hemoglobin-to-Red Cell Distribution Width Ratio in Head and Neck Cancer: Multi-center Cohort Study
Tristan Tham, MD (presenter), Caitlin Olson, MD, Josephine Coury, Julian Khaymovich, Sireesha Teegala, Michael Wotman, and Peter D. Costantino,

How Effective Are Sleep Apnea Mouthpieces?

Sleep is a human necessity but it is becoming more of a luxury as the days go by. There are different distractions that prevent you from sleeping. You actually don’t mind at times that you are losing sleep because you enjoy all these distractions. You like surfing the web. Playing games on your smartphone or video games. There are tons of shows to watch on TV or on the web. You can chat with friends on social media. Unfortunately, there are also conditions that can prevent you from getting enough sleep each night like sleep apnea.

People often associate sleep apnea with snoring because most people with the condition snore. However, not all snorers have sleep apnea. Many people find snoring funny but it is actually a deadly condition. People can die from it because you essentially stop breathing for several seconds multiple times in your sleep. It is not uncommon to see people waking up gasping for air in the middle of the night and not remember a thing the following morning.

Until now, there is no known treatment for sleep apnea just yet but there are treatments that can minimize symptoms, reduce the risk, and improve a person’s life. Surgery isn’t always an option for everyone because of the risks involved. The gold standard is CPAP which stands for continuous positive airway pressure. It delivers air via a mask, which can make it quite a bit uncomfortable …

Better Sleep for Kids Summit – Free Expert Advice for Ages 5-18

better sleep summit for kids


When your kids don’t sleep, neither do you. When the whole family isn’t sleeping well, you start to understand why they use sleep deprivation as a form of torture. Not sleeping hurts. You feel like you’re in a vicious cycle of frustration. I know this feeling well. That’s why the Better Sleep Summit for Kids was developed.

I reached out to childhood anxiety expert Renee Jain. We both serve communities of children and families who count sleep among their challenges. Since anxiety is often a part of insomnia, it was a natural partnership.

Over the last 6 months, Renee and I have interviewed insomnia specialists, sleep doctors, pediatricians, nutritionists, psychologists, mindfulness experts and more to get the best possible (and practical) advice to teach our kids how to sleep better.

Reasons for insomnia in kids 5-18 can include:

  • Anxious thoughts before bed
  • Fear of the dark, robbers, aliens, etc.
  • Separation anxiety from mom, dad, caregivers
  • Devices creating a ‘tired, yet wired’ effect
  • Sleep disruptions including snoring and restlessness
  • Sound, smell, and light disturbances

Sleep is a Skill That Can be Learned at Any Age

If you want to teach your kids how to sleep better, please don’t miss this event.

If you’ve lost hope that your family will ever sleep through the night, this event will change everything! We have selected only the most knowledgeable, respected experts, authors, and teachers to share the latest tools & …

Inspire Medical Systems to Host Symposium, Training Program for Sleep Apnea Device at AAO-HNSF Annual Meeting

Inspire Medical Systems Inc, a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (OSA), will have a presence at the American Academy of Otolaryngology – Head Neck Surgery (AAO-HNSF) Annual Meeting and OTO Experience 2018. The AAO-HNSF Annual Meeting & OTO Experience 2018, which will take place from October 7 – 10, 2018, in Atlanta, GA, is an education and networking event for the otolaryngologist-head and neck surgery community.

“We look forward to further demonstrating our commitment to physician education and awareness through our symposium at the annual AAO-HNS meeting,” says Tim Herbert, president and CEO, in a release. “This well-respected scientific venue provides us with a unique opportunity to share data from our ongoing research studies and highlight the clinically supported benefits of Inspire therapy with physicians from across the country.”

Inspire will host an educational symposium on Monday, October 8, entitled Inspire Leadership Forum: ENT Best Practices for Optimal Patient Outcomes. The symposium, led by Inspire implant ENT surgeons, will include an implant technique review, post-implant patient management best practices, key considerations for incorporating Inspire therapy into an ENT practice, and experiences from private practice and academic settings. Additionally, the symposium will feature the most current update from the 2,500-patient ADHERE registry, Inspire’s global patient registry, which tracks data on safety, effectiveness, weekly usage, overall compliance and satisfaction from patients who have been implanted with

Rhinomed Signs Licensing Agreement with Medical Cannabis Operator to Target Sleep Apnea and Other Sleep Conditions

Melbourne, Australia-based nasal respiratory and sleep company Rhinomed has signed a 12-year exclusive licensing agreement of its nasal platform technology with Columbia Care LLC, a large provider of cannabis-based products and services in the United States.
The agreement covers the license of Rhinomed’s nasal platform for the delivery of medical cannabis and cannabinoid compounds, analogues, and derivatives in the US market. Earlier this year, Rhinomed signed a non-binding term sheet with Columbia Care.

The companies believe that nasally delivered, dose-metered, targeted medical cannabis formulations open up a new pathway and opportunity across a range of indications for this class of medication within the pharmaceutical and over-the-counter consumer health/wellness settings. The program will see Rhinomed’s platform used to develop a range of unique nasally delivered cannabinoid products “in a range of qualifying conditions and symptoms including obstructive sleep apnea, PTSD, pain relief, anti-nausea, and other sleep-related conditions,” states a press release.


Under the terms of the agreement Rhinomed will optimize its platform for delivery of cannabinoid formulations and supply the customized product to Columbia Care. Columbia Care will manufacture and place specific pharmaceutical formulations onto the platform in its facilities in the United States.

Rhinomed will retain all intellectual property rights to its drug delivery platform. Any new intellectual property developed from the collaboration will be owned by the party responsible for the invention. Intellectual property invented jointly by Rhinomed and Columbia Care will be jointly owned by both

The Effect of Mother’s Sleep on an Unborn Baby

How much sleep mothers get when they are pregnant can impact on the health of their growing baby, according to a study conducted by the University of South Australia (UniSA).

Assessing outcomes relating to birth weight, fetal growth, pre-term delivery, and stillbirth, researchers identified four key aspects of maternal sleep that may contribute to poor fetal outcomes.

Lead researcher, UniSA’s associate professor Jane Warland, PhD, says the research gives expectant mothers and clinicians important insights into sleep and heathy pregnancies.

“This study looks into relatively un-navigated territory, at the relationship between fetal health and maternal sleep, mapping commonalties across maternal sleep conditions including sleep apnea, sleep duration, sleep quality, and sleep position,” Warland says in a release. “Adults sleep for a third of their lives, so too an unborn baby, is asleep for a third of their gestation, so it makes sense that maternal sleep could have an impact the health of the fetus. We already know that if a mother sleeps on her back, it can negatively impact the unborn baby, probably by reducing the delivery of oxygen and nutrients to the placenta.

“But across these studies we also found consistencies among mothers suffering from obstructive sleep apnea, short sleeps, and poor quality sleep, which could increase the likelihood of pre-term birth, and perhaps even stillbirth.

“The most significant finding suggested a relationship between premature birth and maternal sleep apnea, with four out of the five larger studies showing

In the Pipeline-Obstructive Sleep Apnea: An Anti-Inflammatory MS Drug Shows Promise for Obstructive Sleep Apnea

A randomized placebo-controlled trial found that four months of treatment with dimethyl fumarate had a significant treatment effect on obstructive sleep apnea severity, reports Neurology Advisor.

“Dimethyl fumarate has anti-inflammatory effects, making it a useful therapy for certain inflammatory conditions,” lead study author and principal investigator Tiffany Braley, MD, MS, assistant professor of neurology at the University of Michigan, told Neurology Today. “Previous evidence has also suggested a role for inflammation in the pathogenesis of OSA, which is further supported by our findings. Although additional research is needed to understand the inflammatory processes underlying OSA, our study suggests that a medication believed to modulate systemic inflammation may partially improve apnea severity.”

Get the full story at

from Sleep Review…

Mayoor Patel Wins American Academy of Craniofacial Pain’s Education Achievement Award

Mayoor Patel, DDS, MS, was awarded the Haden-Stack award during the American Academy of Craniofacial Pain (AACP)’s 33rd Annual International Clinical Symposium.

Named after Jack Haden, DDS, and Brendan Stack, DDS, MS, the AACP created the Haden-Stack Award in 1998 to acknowledge those who have made significant contributions to the advancement of knowledge and clinical practice in the diagnosis and treatment of craniofacial pain and temporomandibular disorders.

Patel graduated from the University of Tennessee with his Doctor of Dental Surgery (DDS) degree. In 2012, he began exclusively treating sleep apnea and craniofacial pain at his practice in Atlanta, the Dental Sleep and Craniofacial Pain Center of Georgia.

Through his knowledge in orofacial pain and dental sleep medicine, Patel works with his patients to help them live pain-free and refreshed. Patel has received over 15 credentials from major organizations related to orofacial pain or sleep apnea, which enables him to treat TMD, orofacial pain, and sleep apnea in his dental office.

“Dr. Patel has a wealth of knowledge and is viewed as an expert in the field of craniofacial pain and dental sleep medicine,” says Gary Demerjian, DDS, longtime colleague of Patel, in a release. “He is passionate in what he does, and it shows in his work as he treats patients and educates other health care professionals.”

Patel has been an active lecturer since 2006 and dedicates much of his time to educating and mentoring hundreds of dentists each year.

New Screening Tool Can Improve Quality of Life for Epilepsy Patients with Sleep Apnea

Rutgers researchers have developed a tool to help neurologists screen for obstructive sleep apnea (OSA) in people with epilepsy whose seizures can be magnified by sleep disorders.

The study appears in the journal Neurology Clinical Practice.

Although detection and treatment of OSA can improve seizure control in some patients with epilepsy, providers have not regularly assessed patients for those risk factors. The researchers developed an electronic health record alert for neurologists to evaluate a patient’s need for a sleep study.

This study can determine the necessity for treatment, which can result in improved seizure control, reduction in antiepileptic medications and reduce the risk of sudden unexpected death in epilepsy.

OSA occurs when breathing is interrupted during sleep. The Epilepsy Foundation estimates that approximately 40% of people living with epilepsy have a higher prevalence of OSA that contributes to poor seizure control.

“Sleep disorders are common among people living with epilepsy and are under-diagnosed,” says lead author Martha A. Mulvey, APN, a nurse practitioner at University Hospital’s department of neurosciences, in a release. “Sleep and epilepsy have a complex reciprocal relationship. Seizures can often be triggered by low oxygen levels that occur during OSA. Sleep deprivation and the interruption of sleep can therefore increase seizure frequency.”

The researchers developed an assessment for identifying OSA consisting of 12 recognized risk factors, which are embedded in the electronic health record. If a patient has at least two risk factors, they are referred

A New Estimate for the Number of People in Europe Who Have Obstructive Sleep Apnea

Roughly 175 million Europeans have obstructive sleep apnea, according to an presented by ResMed at the European Respiratory Society’s (ERS) annual ERS Congress in Paris. Leading researchers estimate 90 million Europeans have moderate to severe sleep apnea, meaning they experience at least 15 breathing events an hour during sleep. These statistics are based on the latest scoring rules for determining one’s apnea–hypopnea index (AASM 2012) and are connected with a 16-country study announced in May 2018 that revealed an estimated 936 million people worldwide have sleep apnea. The new global prevalence is nearly tenfold higher than the previous one—100 million—estimated by the World Health Organization in 2007.

European countries with the highest prevalence are:

  • Russia, 40 million
  • Germany, 26 million
  • France, 24 million
  • Ukraine, 13 million
  • Spain, 9 million
  • United Kingdom, 8 million

“This data is a warning call to Europe’s doctors and other care providers to properly identify, screen and diagnose these people so they can get the life-changing treatment they need,” says Adam Benjafield, PhD, lead researcher and ResMed’s vice president of Medical Affairs, in a release.

Benjafield says one sign of an at-risk patient is whether they have a related chronic medical condition:

  • 83% of people with drug-resistant hypertension have sleep apnea
  • 77% of people with obesity
  • 76% of people with chronic heart failure
  • 72% of people with type 2 diabetes
  • 62% of people with a prior stroke
  • 49% of people with atrial fibrillation

“Doctors should